Anesthesiology, Pain Medicine · Dalton, GA
NPI
1811035371
Since 2007
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1413 Chattanooga Ave
Dalton, GA, 30720
Phone (706) 279-2635
Groups this clinician bills Medicare through
Medicare paid, 2024
$213K
4,557 services
Medicare patients, 2024
332
Average age 66
Drug cost, 2024
$836K
10,456 prescriptions
Company payments, 2025
$673
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nitin Chhabra was code 99214 (office e&m - established), 1,064 times for 265 patients. In total Nitin Chhabra billed 4,557 services in 51 codes, and Medicare paid $213K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,064 | 265 | $79.05 | $84K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 899 | 101 | $0.07 | $65.61 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 538 | 123 | $0.42 | $223 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 401 | 161 | $110.62 | $44K |
| 80307 Drug Tests | Office | 396 | 162 | $60.40 | $24K |
| 96372 Injection Administration | Office | 337 | 130 | $8.46 | $2,851 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 189 | 30 | $0.67 | $126 |
| 99213 Office E&M - Established | Office | 99 | 52 | $54.22 | $5,367 |
| 62323 Nerve Block Injection - Back | Facility | 85 | 59 | $74.90 | $6,366 |
| 27096 Joint Injection | Facility | 80 | 66 | $87.00 | $6,960 |
| 62321 Nerve Block Injection - Back | Facility | 56 | 45 | $77.13 | $4,319 |
| J2360 Injection, orphenadrine citrate, up to 60 mg | Office | 56 | 38 | $5.65 | $316 |
| 20610 Joint Injection | Office | 49 | 32 | $51.88 | $2,542 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 39 | 36 | $50.49 | $1,969 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 39 | 36 | $203.80 | $7,948 |
By year: 2022 $237K for 4,320 services; 2023 $295K for 5,978 services; 2024 $213K for 4,557 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 401 | 161 | $110.62 | $44K |
| 80307 Drug Tests | 396 | 162 | $60.40 | $24K |
Medicare prescription drug claims, 2024
In 2024, the drug Nitin Chhabra prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,107 prescriptions and refills. In total Nitin Chhabra wrote 10,456 Medicare prescriptions that cost $836K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,107 | 2,107 | 327 | $57K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,504 | 1,504 | 240 | $42K |
| Gabapentin Generic | 1,208 | 1,275 | 229 | $14K |
| Tizanidine Hcl Generic | 803 | 891 | 183 | $8,895 |
| Oxycodone Hcl Generic | 642 | 642 | 107 | $11K |
| Pregabalin Generic | 460 | 483 | 93 | $7,607 |
| Cyclobenzaprine Hcl Generic | 366 | 392 | 90 | $2,227 |
| Belbuca Buprenorphine Hcl | 333 | 333 | 62 | $307K |
| Meloxicam Generic | 306 | 359 | 84 | $587 |
| Duloxetine Hcl Generic | 273 | 331 | 49 | $2,802 |
| Baclofen Generic | 227 | 250 | 60 | $2,709 |
| Diclofenac Sodium Generic | 198 | 201 | 50 | $18K |
| Buprenorphine Generic | 197 | 197 | 32 | $69K |
| Methocarbamol Generic | 166 | 179 | 48 | $3,157 |
| Tramadol Hcl Generic | 147 | 147 | 37 | $793 |
Brand drugs: 743 claims; generic drugs: 9,713 claims; opioid claims: 5,294.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nitin Chhabra $673 ($673 in general payments such as food, travel and fees) from 7 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $332.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.